• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Mycologics

Mycologics

Public health solutions inspired by Fungal Research

  • Company
  • Food Security
  • Health and Wellness
    • Publications
  • Collaborators
  • Updates

Search Mycologics

Acute and short-term administrations of delta-9-tetrahydrocannabinol modulate major gut metabolomic regulatory pathways in C57BL/6 mice.

Anindya Chanda · October 14, 2019 ·

Delta-9-tetrahydrocannabinol (THC) is the primary psychoactive compound in Cannabis, which is studied extensively for its medicinal value. A central gap in the science is the underlying mechanisms surrounding THC’s therapeutic effects and the role of gut metabolite profiles. Using a mass-spectrometry based metabolomics, we show here that intraperitoneal injection of THC in C57BL/6 mice modulates metabolic profiles that have previously been identified as integral to health. Specifically, we investigated the effects of acute (single THC injection denoted here as ‘1X’) and short -term (five THC injections on alternate days denoted as ‘5X’) THC administration on fecal and intestinal tissue metabolite profiles. Results are consistent with the hypothesis that THC administration alters host metabolism by targeting two prominent lipid metabolism pathways: glycerophospholipid metabolism and fatty acid biosynthesis.

[ctd_show_acute_article ]

Category iconPublications

Footer

Contact Us

Mycologics LLC
2 Davis Dr.,
Durham, NC 27709

P: (240) 339-5004

Recent Publications featuring Our Research

  • Bioremoval of PVP-coated silver nanoparticles using Aspergillus niger: the role of exopolysaccharides
  • Increased prevalence of indoor Aspergillus and Penicillium species is associated with indoor flooding and coastal proximity: a case study of 28 moldy buildings

Copyright © 2022 Mycologics · All Rights Reserved ·

 Website by Code the Dream & Tomatillo Design